Page URL:

Novel CRISPR approach uses an on-off switch for epigenome editing

19 April 2021
Appeared in BioNews 1091

Reversible genome-wide epigenome editing may be possible with a new approach using cellular memory to silence gene expression.

US researchers designed a protein complex that selectively and reversibly decreases gene expression by attaching methyl tags to DNA, preventing access by genome decoding machinery – effectively 'switching off' the target gene  without altering the DNA sequence.

Previously, it was believed that only genes containing a specific sequence called a CpG site could be methylated, but the new complex – named CRISPRoff – is not limited by this requirement.

'That was a huge shock even for us, because we thought it was only going to be applicable for a subset of genes', said first author Dr James Nuñez from the University of California, San Francisco.  

'Since we now can sort of silence any part of the genome that we want, it's a great tool for exploring the function of the genome,' said co-senior author Professor Jonathan Weissman from the Massachusetts Institute of Technology.

Targeting the MAPT gene which encodes the tau protein associated with Alzheimer's disease, the CRISPRoff system significantly downregulated gene expression. After silencing the gene in stem cells, these were chemically transformed into neurons and maintained a 90 percent reduction in gene expression. This demonstrated epigenetic inheritance – a form of cellular memory.

'I think our tool really allows us to begin to study the mechanism of heritability, especially epigenetic heritability, which is a huge question in the biomedical sciences,' said Dr Nuñez.

Adapted from the bacterial CRISPR/Cas9 system, CRISPRoff has advantages over existing epigenetic editing approaches which required constant expression of artificial proteins to regulate gene expression. The team also developed the complementary 'CRISPRon' – a complex which removes the methyl tags, meaning the epigenetic edits are fully reversible.

Professor Weissman highlighted the potential therapeutic use of the approach, but cautioned that applying the approach in vivo would not be straightforward: 'The question is, then, how do you deliver this to an adult? And would it really be enough to impact Alzheimer's? Those are big open questions, especially the latter.'

The paper was published in the journal Cell.

A CRISPR on-off switch for genes controls expression without altering DNA
The Science Advisory Board |  12 April 2021
An on-off switch for genome editing
Whitehead Institute |  9 April 2021
CRISPR breakthrough: Scientists can now turn genes on and off at whim
Interesting Engineering |  9 April 2021
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
Cell |  9 April 2021
MIT and UCSF researchers create CRISPR 'on-off switch' that controls gene expression without changing DNA
Fierce Biotech |  9 April 2021
Scientists develop CRISPR-off for controlling gene expression through heritable epigenetic memory
Genetic Engineering and Biotechnology News |  9 April 2021
13 September 2021 - by Dr George Janes 
Potential applications of CRISPR could be broadened by a new miniature version of the genome editing approach...
10 May 2021 - by Rachel Siden 
A new genome editing approach may be faster and simpler than CRISPR...
26 April 2021 - by Tsvetana Stoilova 
A new genome editing approach that replaces a mutated gene with a functional gene copy has the potential to treat monogenic diseases...
22 March 2021 - by Eleanor Taylor 
As part of the 'Spotlight on….' series, the MIT Technology Review recently focused their attention on the genome editing 'supertool' CRISPR...
15 March 2021 - by Dr Yvonne Collins 
Scientific American in partnership with Cellectis, hosted a virtual event to explore genome editing and its use in the clinic. Three pioneers of the field were invited to discuss the early days of genome editing, new technologies and future challenges...
14 September 2020 - by Rowda Dahir 
The safety and efficiency of CRISPR genome editing can be improved by identifying the best genome editing option for a specific application...
27 July 2020 - by Christina Burke 
An exceptionally small CRISPR-associated enzyme, which may significantly increase the efficacy of human genome editing, has been discovered by US researchers...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.